A validated UPLC-MS/MS method for the quantitation of an unstable peptide, monocyte locomotion inhibitory factor

Xuemei Liu1, Pei Hu1, Yongsheng Wang2

  • 1Clinical Pharmacology Research Center, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100730, PR China; Beijing Key Laboratory of Clinical PK and PD Investigation for Innovative Drugs, PR China.

Insights

A new ultra-performance liquid chromatography-tandem mass spectrometry method accurately measures Monocyte Locomotion Inhibitory Factor (MLIF) in human plasma. This validated assay is crucial for pharmacokinetic studies of MLIF, a peptide used for neural protection in stroke.

Area of Science:

  • Analytical Chemistry
  • Pharmacokinetics
  • Neuroscience

Background:

  • Monocyte Locomotion Inhibitory Factor (MLIF) is a pentapeptide with anti-inflammatory properties, investigated for neural protection in acute ischemic stroke.
  • Accurate quantification of MLIF in human plasma is essential for pharmacokinetic evaluation in clinical trials.
  • Peptide instability in biological matrices presents a significant challenge for bioanalytical method development.

Purpose of the Study:

  • To develop and validate a sensitive and reliable ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) method for measuring MLIF in human plasma.
  • To address and overcome the challenge of MLIF instability in plasma samples.
  • To apply the validated method in a first-in-human study.

Main Methods:

  • Human plasma samples were prepared using protein precipitation followed by acidification with sulfuric acid to ensure MLIF stability.
  • Chromatographic separation was performed on an ACQUITY UPLC HSS T3 column using a gradient elution with acetonitrile and formic acid in water.
  • MLIF was detected using a Xevo TQ-S tandem mass spectrometer with positive electrospray ionization in multiple reaction monitoring (MRM) mode.

Main Results:

  • The UPLC-MS/MS method was fully validated for MLIF quantification over a concentration range of 0.5-40 ng/mL, with a lower limit of quantification (LLOQ) of 0.5 ng/mL.
  • The method demonstrated excellent precision (inter- and intra-batch ≤ 8.8%) and accuracy (88.7-104.2%), with a mean extraction recovery of 43.3% and no significant matrix effect.
  • The developed method confirmed MLIF stability under various handling and storage conditions post-acidification.

Conclusions:

  • A robust and sensitive UPLC-MS/MS method was successfully established for the accurate determination of MLIF in human plasma.
  • The method's validation and stability assessments confirm its suitability for pharmacokinetic studies.
  • The method was successfully applied to a first-in-human study of MLIF in healthy Chinese subjects, enabling crucial pharmacokinetic evaluations.

Related Concept Videos

Reliability and Validity01:29

Reliability and Validity

Reliability and validity are two important considerations that must be made with any type of data collection. Reliability refers to the ability to consistently produce a given result. In the context of psychological research, this would mean that any instruments or tools used to collect data do so in consistent, reproducible ways.
14.1K
Measurement of Bioavailability: Pharmacokinetic Methods01:30

Measurement of Bioavailability: Pharmacokinetic Methods

Pharmacokinetics is a vital branch of pharmacology that examines how drugs are absorbed, distributed, metabolized, and excreted by the body. Two key methodologies in pharmacokinetics are plasma drug concentration studies and urinary drug excretion analyses, both of which provide critical insights into a drug's therapeutic efficacy and bioavailability.Plasma Drug Concentration-Time StudiesPlasma drug concentration-time studies involve analyzing blood samples at specific intervals to quantify...
292
Peptide Bonds02:43

Peptide Bonds

A peptide bond covalently attaches amino acids through a dehydration reaction. One amino acid's carboxyl group and another amino acid's amino group combine, releasing a water molecule. The resulting bond is the peptide bond. The products that such linkages form are peptides. As more amino acids join this growing chain, the resulting chain is a polypeptide. Each polypeptide has a free amino group at one end. This end has the N-terminal, or the amino-terminal, and the other end has a free...
83.4K
Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels01:31

Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels

Renal clearance of a drug is influenced by various factors, including its physicochemical properties and plasma levels. These factors play a significant role in determining how efficiently the kidneys eliminate a drug.
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
604
Transcription Factors02:16

Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
82.9K
Data Validation01:15

Data Validation

Method validation is a crucial process in analytical chemistry designed to confirm that a given method consistently produces reliable and high-quality results. This process is essential when a method is applied to different sample matrices or when procedural modifications are made, ensuring that the results meet acceptable standards across various applications.
Key parameters for method validation include:
2.1K